Tomas Pitra1, Kristyna Pivovarcikova2, Radek Tupy3, Reza Alaghehbandan4, Tana Barakova3, Ivan Travnicek5, Kristyna Prochazkova5, Tobias Klatte6, Piotr Chlosta7, Ondrej Hes2, Milan Hora5. 1. Department of Urology, Medical Faculty, Charles University, Charles University Hospital Plzen, E. Beneše 13, 305 99, Plzeň, Czech Republic. pitrat@fnplzen.cz. 2. Department of Pathology, Medical Faculty, Charles University, Charles University Hospital Plzen, Plzeň, Czech Republic. 3. Department of Radiology, Medical Faculty, Charles University, Charles University Hospital Plzen, Plzeň, Czech Republic. 4. Department of Pathology, Faculty of Medicine, University of British Columbia, Royal Columbian Hospital, Vancouver, BC, Canada. 5. Department of Urology, Medical Faculty, Charles University, Charles University Hospital Plzen, E. Beneše 13, 305 99, Plzeň, Czech Republic. 6. Department of Urology, Medical University of Vienna, Vienna, Austria. 7. Department of Urology, Jagiellonian University Medical College, Kraków, Poland.
Abstract
INTRODUCTION: CT imaging is the standard examination for renal cystic lesions and defines the Bosniak category, which dictates further management. Given that Bosniak II/IIF/III renal cystic lesions can potentially harbor renal cell carcinoma (RCC), additional diagnostic modalities may be required in management decision making. AIM: To determine the value of additional magnetic resonance imaging in CT-defined Bosniak IIF-III renal cystic lesions. MATERIALS AND METHODS: This a multicenter retrospective study of 46 consecutive patients, diagnosed with cystic renal lesions between 2009 and 2016. The inclusion criteria were: (1) cystic renal lesion classified as Bosniak IIF-III on CT, (2) a subsequent MRI examination, and (3) documented outcome via surgery for cystic renal mass or follow-up. RESULTS: 46 patients (35 males, 11 females) were included. The mean size of the cystic lesion was 3.92 cm (0.7-10 cm). According to the CT findings, Bosniak IIF and III were found in 12 (26.1%) and 34 (73.9%) cases. Reclassification of Bosniak category was done after MRI examination in 31 cases (67.4%). An upgrade rate of 58.7% (27 cases) to a higher category was made, while the downgrade rate to a lower category was achieved in 4 cases (8.7%). As a result, significant therapeutic management change was made in 12/31 patients (38.7%), of whom 8 underwent subsequent surgery. CONCLUSION: MRI study may reduce the use of Bosniak IIF category (in comparison with CT), which has a direct impact on therapeutic management (surgery vs. surveillance) in a significant proportion of patients.
INTRODUCTION: CT imaging is the standard examination for renal cystic lesions and defines the Bosniak category, which dictates further management. Given that Bosniak II/IIF/III renal cystic lesions can potentially harbor renal cell carcinoma (RCC), additional diagnostic modalities may be required in management decision making. AIM: To determine the value of additional magnetic resonance imaging in CT-defined Bosniak IIF-III renal cystic lesions. MATERIALS AND METHODS: This a multicenter retrospective study of 46 consecutive patients, diagnosed with cystic renal lesions between 2009 and 2016. The inclusion criteria were: (1) cystic renal lesion classified as Bosniak IIF-III on CT, (2) a subsequent MRI examination, and (3) documented outcome via surgery for cystic renal mass or follow-up. RESULTS: 46 patients (35 males, 11 females) were included. The mean size of the cystic lesion was 3.92 cm (0.7-10 cm). According to the CT findings, Bosniak IIF and III were found in 12 (26.1%) and 34 (73.9%) cases. Reclassification of Bosniak category was done after MRI examination in 31 cases (67.4%). An upgrade rate of 58.7% (27 cases) to a higher category was made, while the downgrade rate to a lower category was achieved in 4 cases (8.7%). As a result, significant therapeutic management change was made in 12/31 patients (38.7%), of whom 8 underwent subsequent surgery. CONCLUSION: MRI study may reduce the use of Bosniak IIF category (in comparison with CT), which has a direct impact on therapeutic management (surgery vs. surveillance) in a significant proportion of patients.
Entities:
Keywords:
Cystic tumor; Imaging; Kidney; Magnetic resonance; Renal cyst
Authors: Milan Hora; Ondrej Hes; Michal Michal; Ludmila Boudová; Zdenek Chudácek; Boris Kreuzberg; Jirí Klecka Journal: Int Urol Nephrol Date: 2005 Impact factor: 2.370